Furthermore, we recently identified a recurrent gain-of-function mutation of MMSET (E1099K) most commonly found in lymphoid malignancies, which enhances its methyltransferase activity and may functionally mimic overexpression seen in other cancers [24], [25]. The gene discussed is NSD2; the disease is cancer.